Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Disposition to Issuer of 164,472 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 164,472 | n/a |
| Jun 17, 2026 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 63,481 | n/a |
| Jun 1, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 79,873 | n/a |
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 41,800 | n/a |
| Jun 12, 2025 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 45,000 | n/a |
| Jun 2, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 33,000 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,167 | n/a |
| Jun 21, 2024 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 24,311 | n/a |
| May 24, 2024 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 23,000 | n/a |
| May 22, 2024 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 2,917 | n/a |